Skip to content
10-K

Annual Report

Panacea Life Sciences Holdings, Inc. PLSH

0001493152-24-012107

← back to feed
Filed
Apr 1, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 15, 2024 17.65M sh
Shares Diluted FY 2023 · Dec 31, 2023 16.63M sh
Shares Diluted FY 2023 · Dec 31, 2022 14.86M sh
Capex FY 2023 · Dec 31, 2023 $65.32K
Capex FY 2023 · Dec 31, 2022 $243.8K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$1.52M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$2.4M
Cash And Equivalents FY 2023 · Dec 31, 2023 $100.92K
Cash And Equivalents FY 2023 · Dec 31, 2022 $6.95K
Stockholders Equity FY 2023 · Dec 31, 2023 −$8.29M
Stockholders Equity FY 2023 · Dec 31, 2022 −$2.14M
Current Liabilities FY 2023 · Dec 31, 2023 $19.45M
Current Liabilities FY 2023 · Dec 31, 2022 $15.07M
Total Liabilities FY 2023 · Dec 31, 2023 $26.27M
Total Liabilities FY 2023 · Dec 31, 2022 $21.63M
Current Assets FY 2023 · Dec 31, 2023 $4.66M
Current Assets FY 2023 · Dec 31, 2022 $6.38M
Total Assets FY 2023 · Dec 31, 2023 $17.98M
Total Assets FY 2023 · Dec 31, 2022 $19.49M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.48
Eps Diluted FY 2023 · Dec 31, 2022 −$0.62
Eps Basic FY 2023 · Dec 31, 2023 −$0.48
Eps Basic FY 2023 · Dec 31, 2022 −$0.62
Sga Expense FY 2023 · Dec 31, 2023 $1.46M
Sga Expense FY 2023 · Dec 31, 2022 $1.09M
Net Income FY 2023 · Dec 31, 2023 −$8.02M
Net Income FY 2023 · Dec 31, 2022 −$9.14M
Operating Income FY 2023 · Dec 31, 2023 −$5.55M
Operating Income FY 2023 · Dec 31, 2022 −$5.65M
Gross Profit FY 2023 · Dec 31, 2023 $1.12M
Gross Profit FY 2023 · Dec 31, 2022 $396.47K
Cost Of Revenue FY 2023 · Dec 31, 2023 $1.26M
Cost Of Revenue FY 2023 · Dec 31, 2022 $1.23M
Revenue FY 2023 · Dec 31, 2023 $2.38M
Revenue FY 2023 · Dec 31, 2022 $1.63M